Literature DB >> 11701097

The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review.

J Chilcott1, J Wight, M Lloyd Jones, P Tappenden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11701097     DOI： 10.3310/hta5190

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN： 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  2 in total

1.  Postmarketing surveillance study of the efficacy and tolerability of pioglitazone in insulin-resistant patients with type 2 diabetes mellitus in general practice.

Authors:  Christof Schöfl; Georg Lübben
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 2.  Pioglitazone for type 2 diabetes mellitus.

Authors:  B Richter; E Bandeira-Echtler; K Bergerhoff; C Clar; S H Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.